Propofol enhances BCR-ABL TKIs' inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression.
BMC Anesthesiol
; 17(1): 132, 2017 Sep 29.
Article
in En
| MEDLINE
| ID: mdl-28962554
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Propofol
/
Fusion Proteins, bcr-abl
/
Protein Kinase Inhibitors
/
Proto-Oncogene Proteins c-akt
/
TOR Serine-Threonine Kinases
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
BMC Anesthesiol
Year:
2017
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom